DK0974589T3 - Benzimidazolderivater og farmaceutiske acceptable salte deraf - Google Patents
Benzimidazolderivater og farmaceutiske acceptable salte derafInfo
- Publication number
- DK0974589T3 DK0974589T3 DK98951721T DK98951721T DK0974589T3 DK 0974589 T3 DK0974589 T3 DK 0974589T3 DK 98951721 T DK98951721 T DK 98951721T DK 98951721 T DK98951721 T DK 98951721T DK 0974589 T3 DK0974589 T3 DK 0974589T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- hydrocarbon radical
- acute
- inflammatory diseases
- chronic inflammatory
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 208000030090 Acute Disease Diseases 0.000 abstract 3
- 230000001154 acute effect Effects 0.000 abstract 3
- 208000037976 chronic inflammation Diseases 0.000 abstract 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 230000003266 anti-allergic effect Effects 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 2
- 239000000043 antiallergic agent Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000003449 preventive effect Effects 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 230000017307 interleukin-4 production Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30572097 | 1997-11-07 | ||
| PCT/JP1998/005011 WO1999024425A1 (en) | 1997-11-07 | 1998-11-06 | Benzimidazole derivatives and pharmaceutically acceptable salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0974589T3 true DK0974589T3 (da) | 2004-05-03 |
Family
ID=17948547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98951721T DK0974589T3 (da) | 1997-11-07 | 1998-11-06 | Benzimidazolderivater og farmaceutiske acceptable salte deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6248768B1 (da) |
| EP (1) | EP0974589B1 (da) |
| JP (1) | JP3271991B2 (da) |
| KR (1) | KR100401314B1 (da) |
| AT (1) | ATE259797T1 (da) |
| AU (1) | AU738772B2 (da) |
| CA (1) | CA2276405C (da) |
| DE (1) | DE69821749T2 (da) |
| DK (1) | DK0974589T3 (da) |
| ES (1) | ES2216322T3 (da) |
| PT (1) | PT974589E (da) |
| WO (1) | WO1999024425A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0308537A (pt) * | 2002-03-20 | 2005-02-09 | Metabolex Inc | Composto, composição, e métodos para tratar diabetes tipo 2 e hiperuricemia, para modular resistência a insulina e para aliviar hiperlipidemia em um indivìduo e agente de prodroga |
| EP1359773B1 (en) * | 2002-04-15 | 2016-08-24 | Microsoft Technology Licensing, LLC | Facilitating interaction between video renderers and graphics device drivers |
| KR100533460B1 (ko) * | 2002-07-20 | 2005-12-08 | 대화제약 주식회사 | 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법 |
| US7199259B2 (en) * | 2003-06-20 | 2007-04-03 | Metabolex, Inc. | Resolution of α-(phenoxy)phenylacetic acid derivatives |
| US20050222234A1 (en) * | 2004-03-31 | 2005-10-06 | Taiho Pharmaceutical Co., Ltd. | Mucin production inhibitor |
| AU2005247473A1 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Substituted triazoles as modulators of PPAR and methods of their preparation |
| WO2005115384A2 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| US7714131B2 (en) | 2005-09-23 | 2010-05-11 | Metabolex, Inc. | Process for the stereoselective preparation of (−)-halofenate and derivatives thereof |
| CN103739554B (zh) * | 2013-12-31 | 2016-01-20 | 陕西科技大学 | 一种制备2-烷基苯并咪唑类化合物的方法 |
| CN120097921A (zh) * | 2024-07-05 | 2025-06-06 | 广东省科学院动物研究所 | 二氟甲氧基苯基类pde4抑制剂及其应用 |
| CN121609673A (zh) * | 2026-02-02 | 2026-03-06 | 五邑大学 | 一种pde4抑制剂及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9307570A (pt) * | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
| PE27997A1 (es) * | 1994-04-29 | 1997-09-20 | Lilly Co Eli | Antagonistas de receptores de taquicininas |
| US5563143A (en) * | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
-
1998
- 1998-11-06 AU AU97621/98A patent/AU738772B2/en not_active Ceased
- 1998-11-06 AT AT98951721T patent/ATE259797T1/de not_active IP Right Cessation
- 1998-11-06 KR KR10-1999-7006155A patent/KR100401314B1/ko not_active Expired - Fee Related
- 1998-11-06 DK DK98951721T patent/DK0974589T3/da active
- 1998-11-06 JP JP52595599A patent/JP3271991B2/ja not_active Expired - Fee Related
- 1998-11-06 ES ES98951721T patent/ES2216322T3/es not_active Expired - Lifetime
- 1998-11-06 US US09/341,277 patent/US6248768B1/en not_active Expired - Fee Related
- 1998-11-06 EP EP98951721A patent/EP0974589B1/en not_active Expired - Lifetime
- 1998-11-06 PT PT98951721T patent/PT974589E/pt unknown
- 1998-11-06 WO PCT/JP1998/005011 patent/WO1999024425A1/ja not_active Ceased
- 1998-11-06 DE DE69821749T patent/DE69821749T2/de not_active Expired - Fee Related
- 1998-11-06 CA CA002276405A patent/CA2276405C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2276405A1 (en) | 1999-05-20 |
| US6248768B1 (en) | 2001-06-19 |
| DE69821749T2 (de) | 2004-07-29 |
| ES2216322T3 (es) | 2004-10-16 |
| EP0974589A1 (en) | 2000-01-26 |
| EP0974589A4 (en) | 2001-07-25 |
| AU738772B2 (en) | 2001-09-27 |
| DE69821749D1 (de) | 2004-03-25 |
| CA2276405C (en) | 2003-06-24 |
| KR20000069942A (ko) | 2000-11-25 |
| WO1999024425A1 (en) | 1999-05-20 |
| ATE259797T1 (de) | 2004-03-15 |
| EP0974589B1 (en) | 2004-02-18 |
| AU9762198A (en) | 1999-05-31 |
| KR100401314B1 (ko) | 2003-10-10 |
| JP3271991B2 (ja) | 2002-04-08 |
| PT974589E (pt) | 2004-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062692L (no) | Heterosykliske MEK inhibitorer og fremgangsmater for anvendelse derav | |
| NO20055421L (no) | Kinolinderivater som fosfodiestrase-inhibitorer | |
| TW430660B (en) | Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them | |
| YU20999A (sh) | Heterociklični derivati koji inhibiraju faktor xa | |
| EP0742218A4 (en) | PYRROLOPYRIDAZINE DERIVATIVES | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| NO20073393L (no) | [1,2,4]tnazolo [4,3-A] pyridin derivater for behandlingen av hyperproliferative sykdommer | |
| CA2239227A1 (en) | Nitrogen-containing heterocyclic compounds | |
| DE60103147D1 (de) | 1,1-dioxoisothiazolidin-substituierte indazole als inhibitoren der zellproliferation | |
| TR200001279T2 (tr) | Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler. | |
| TW377352B (en) | Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof | |
| NO20055565L (no) | Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO) | |
| ATE259797T1 (de) | Benzimidazol-derivate und ihre pharmazeutisch verträglichen salze | |
| WO2000068198A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
| CA2238875A1 (en) | Tri-aryl ethane derivatives as pde iv inhibitors | |
| WO2000064874A3 (en) | Heterosubstituted pyridine derivatives as pde 4 inhibitors | |
| NO20052182L (no) | Nye forbindelser | |
| ATE247964T1 (de) | Als inhibitoren der aicarftnützliche verbindungen | |
| NO20053483L (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
| MX2007001267A (es) | Derivados de naftiridinas 2,8-disustituidas. | |
| WO2005053702A3 (en) | Anti-inflammatory agents | |
| EP0894799A4 (en) | INDOLOMORPHINANE DERIVATIVES AND PREVENTIVE MEDICINES / REMEDIES FOR BRAIN DISORDERS | |
| EP0990645A4 (en) | NEW SULFONAMIDE DERIVATIVES | |
| EP1201664A4 (en) | BEMZIMIDAZOLE COMPOUNDS AND DRUGS CONTAINING THEM | |
| ATE240329T1 (de) | Zytotoxische pyrido(2,3,4-kl)acridinderivate, ihre herstellung und therapeutische verwendung |